Search research articles
Contact Us
Filters
Showing results (111-120 of 160) with videos related to
Page
of 16
Sort By:
Pharmacogenomics
|
August 22, 2014
Influence of donor-recipient CYP3A4/5 genotypes, age and fluconazole on tacrolimus pharmacokinetics in pediatric liver transplantation: a population approach
Vanessa Guy-Viterbo, Henry Baudet, Laure Elens, et al.
Acta Clinica Belgica
|
January 11, 2021
Joint Belgian recommendation on screening for DPD-deficiency in patients treated with 5-FU, capecitabine (and tegafur)
Veerle Casneuf, Ivan Borbath, Marc Van den Eynde, et al.
British Journal of Pharmacology
|
February 5, 2025
Silencing drug transporters in human primary muscle cells modulates atorvastatin pharmacokinetics: A pilot study
Emilia Hoste, Louise Deldicque, Giulio G Muccioli, et al.
Pharmacogenetics
|
May 29, 2004
The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients
Vincent Haufroid, Michel Mourad, Valérie Van Kerckhove, et al.
The Journal of Infectious Diseases
|
March 4, 2025
Dolutegravir and Risk of Neuropsychiatric Adverse Events: a Pharmacogenetic Study
Julien De Greef, Jean Cyr Yombi, Anne Vincent, et al.
Clinical Pharmacology and Therapeutics
|
October 17, 2023
Tacrolimus Pharmacokinetics is Associated with Gut Microbiota Diversity in Kidney Transplant Patients: Results from a Pilot Cross-Sectional Study
Alexandra L Degraeve, Laure B Bindels, Vincent Haufroid, et al.
The Journal of Biological Chemistry
|
April 25, 2021
The metalloprotein YhcH is an anomerase providing N-acetylneuraminate aldolase with the open form of its substrate
Takfarinas Kentache, Leopold Thabault, Gladys Deumer, et al.
Pharmacogenomics
|
January 19, 2013
CYP3A4 intron 6 C>T SNP (CYP3A4*22) encodes lower CYP3A4 activity in cancer patients, as measured with probes midazolam and erythromycin
Laure Elens, Annemieke Nieuweboer, Stephen J Clarke, et al.
Therapeutic Drug Monitoring
|
July 11, 2012
Endoxifen levels and its association with CYP2D6 genotype and phenotype: evaluation of a southern Brazilian population under tamoxifen pharmacotherapy
Marina V Antunes, Rafael Linden, Tamyris V Santos, et al.
Clinical Chemistry
|
March 14, 2024
Laboratory Testing for Endocrine Hypertension: Current and Future Perspectives
Louisiane Courcelles, Maria Stoenoiu, Vincent Haufroid, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 160) with videos related to
Sort By:
Page
of 16
Pharmacogenomics
|
August 22, 2014
Influence of donor-recipient CYP3A4/5 genotypes, age and fluconazole on tacrolimus pharmacokinetics in pediatric liver transplantation: a population approach
Vanessa Guy-Viterbo, Henry Baudet, Laure Elens, et al.
Acta Clinica Belgica
|
January 11, 2021
Joint Belgian recommendation on screening for DPD-deficiency in patients treated with 5-FU, capecitabine (and tegafur)
Veerle Casneuf, Ivan Borbath, Marc Van den Eynde, et al.
British Journal of Pharmacology
|
February 5, 2025
Silencing drug transporters in human primary muscle cells modulates atorvastatin pharmacokinetics: A pilot study
Emilia Hoste, Louise Deldicque, Giulio G Muccioli, et al.
Pharmacogenetics
|
May 29, 2004
The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients
Vincent Haufroid, Michel Mourad, Valérie Van Kerckhove, et al.
The Journal of Infectious Diseases
|
March 4, 2025
Dolutegravir and Risk of Neuropsychiatric Adverse Events: a Pharmacogenetic Study
Julien De Greef, Jean Cyr Yombi, Anne Vincent, et al.
Clinical Pharmacology and Therapeutics
|
October 17, 2023
Tacrolimus Pharmacokinetics is Associated with Gut Microbiota Diversity in Kidney Transplant Patients: Results from a Pilot Cross-Sectional Study
Alexandra L Degraeve, Laure B Bindels, Vincent Haufroid, et al.
The Journal of Biological Chemistry
|
April 25, 2021
The metalloprotein YhcH is an anomerase providing N-acetylneuraminate aldolase with the open form of its substrate
Takfarinas Kentache, Leopold Thabault, Gladys Deumer, et al.
Pharmacogenomics
|
January 19, 2013
CYP3A4 intron 6 C>T SNP (CYP3A4*22) encodes lower CYP3A4 activity in cancer patients, as measured with probes midazolam and erythromycin
Laure Elens, Annemieke Nieuweboer, Stephen J Clarke, et al.
Therapeutic Drug Monitoring
|
July 11, 2012
Endoxifen levels and its association with CYP2D6 genotype and phenotype: evaluation of a southern Brazilian population under tamoxifen pharmacotherapy
Marina V Antunes, Rafael Linden, Tamyris V Santos, et al.
Clinical Chemistry
|
March 14, 2024
Laboratory Testing for Endocrine Hypertension: Current and Future Perspectives
Louisiane Courcelles, Maria Stoenoiu, Vincent Haufroid, et al.
Page
of 16